| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.26B | 2.18B | 2.24B | 2.58B | 1.62B | 976.59M |
| Gross Profit | 488.72M | 474.06M | 466.10M | 556.75M | 372.91M | 187.81M |
| EBITDA | 185.81M | 169.82M | 161.86M | 343.35M | 184.79M | 90.02M |
| Net Income | 44.76M | 46.48M | 36.05M | 128.67M | 103.14M | 28.03M |
Balance Sheet | ||||||
| Total Assets | 1.48B | 1.40B | 1.23B | 1.43B | 1.11B | 459.52M |
| Cash, Cash Equivalents and Short-Term Investments | 23.33M | 33.74M | 13.00M | 65.07M | 7.76M | 457.98K |
| Total Debt | 654.96M | 623.07M | 564.03M | 789.86M | 570.59M | 166.61M |
| Total Liabilities | 834.01M | 763.08M | 705.25M | 922.00M | 700.89M | 220.06M |
| Stockholders Equity | 650.84M | 634.57M | 526.87M | 506.97M | 414.03M | 239.46M |
Cash Flow | ||||||
| Free Cash Flow | 94.19M | 133.54M | 226.30M | 199.88M | -72.88M | 61.75M |
| Operating Cash Flow | 104.97M | 142.75M | 238.08M | 210.69M | -65.42M | 64.19M |
| Investing Cash Flow | -9.30M | -147.46M | -13.48M | -279.47M | -306.63M | ― |
| Financing Cash Flow | -84.48M | 30.00M | -285.99M | 128.61M | 378.85M | ― |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | C$864.03M | 11.12 | 12.33% | 5.85% | 28.20% | 36.95% | |
73 Outperform | C$2.71B | 16.54 | 10.04% | 3.88% | 8.15% | -3.57% | |
72 Outperform | C$786.61M | 7.82 | 11.43% | 4.27% | 8.54% | 33.89% | |
69 Neutral | C$619.08M | 13.44 | 8.84% | 5.09% | 3.71% | -12.70% | |
66 Neutral | C$926.62M | 15.21 | 6.99% | 1.74% | 7.18% | -9.38% | |
64 Neutral | C$378.89M | 8.63 | 11.85% | ― | 2.99% | -12.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
ADENTRA Inc. announced strong financial results for the third quarter of 2025, with sales reaching $592.1 million, marking a 4.1% increase from the previous year. The company reported a slight increase in gross margin and a stable basic earnings per share. ADENTRA’s strategic acquisitions, such as the Woolf transaction, have contributed to its growth, and the company has effectively managed its capital to reduce debt and return value to shareholders. The announcement also highlighted the impact of US tariffs, which are now limited to country-specific rates, and the company’s preparedness to handle these tariffs without significant impact on margins. Looking ahead, ADENTRA plans to focus on reducing leverage and pursuing strategic acquisitions in 2026.
The most recent analyst rating on (TSE:ADEN) stock is a Hold with a C$37.00 price target. To see the full list of analyst forecasts on ADENTRA stock, see the TSE:ADEN Stock Forecast page.